Literature DB >> 8278462

Podophyllotoxin, steganacin and combretastatin: natural products that bind at the colchicine site of tubulin.

D L Sackett1.   

Abstract

A large number of antimicrotubule agents are known that bind to tubulin in vitro and disrupt microtubule assembly in vitro and in vivo. Many of these agents bind to the same site on the tubulin molecule, as does colchicine. Of these, the natural products podophyllotoxin, steganacin and combretastatin are the subjects of this review. For each of these, the chemistry and biochemistry are described. Particular attention is given to stereochemical considerations. Biosynthetic pathways for podophyllotoxin and congeners are surveyed. The binding to tubulin and the effects on microtubule assembly and disassembly are described and compared. In addition, structural features important to binding are examined using available analogs. Several features significant for tubulin interaction are common to these compounds and to colchicine. These are described and the implications for tubulin structure are discussed. The manifold results of applying these agents to biological systems are reviewed. These actions include effects that are clearly microtubule mediated and others in which the microtubule role is less obvious. Activity of some of these compounds due to inhibition of DNA topoisomerase is discussed. The range of species in which these compounds occur is examined and in the case of podophyllotoxin is found to be quite broad. In addition, the range of species that are sensitive to the effects of these compounds is discussed.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8278462     DOI: 10.1016/0163-7258(93)90044-e

Source DB:  PubMed          Journal:  Pharmacol Ther        ISSN: 0163-7258            Impact factor:   12.310


  22 in total

1.  Design, synthesis, and cytotoxicity of perbutyrylated glycosides of 4β-triazolopodophyllotoxin derivatives.

Authors:  Cheng-Ting Zi; Zhen-Hua Liu; Gen-Tao Li; Yan Li; Jun Zhou; Zhong-Tao Ding; Jiang-Miao Hu; Zi-Hua Jiang
Journal:  Molecules       Date:  2015-02-16       Impact factor: 4.411

2.  Inhibition of CYP3A4 and CYP2C9 by podophyllotoxin: implication for clinical drug-drug interactions.

Authors:  Jin-Hui Song; Dong-Xue Sun; Bin Chen; Dai-Hong Ji; Jie Pu; Jie Xu; Feng-De Tian; Lin Guo
Journal:  J Biosci       Date:  2011-12       Impact factor: 1.826

Review 3.  Measurement of ligand binding to tubulin by sulfhydryl reactivity.

Authors:  Adrian Begaye; Dan L Sackett
Journal:  Methods Cell Biol       Date:  2010       Impact factor: 1.441

4.  Structure Guided Design, Synthesis, and Biological Evaluation of Novel Benzosuberene Analogues as Inhibitors of Tubulin Polymerization.

Authors:  Haichan Niu; Tracy E Strecker; Jeni L Gerberich; James W Campbell; Debabrata Saha; Deboprosad Mondal; Ernest Hamel; David J Chaplin; Ralph P Mason; Mary Lynn Trawick; Kevin G Pinney
Journal:  J Med Chem       Date:  2019-05-24       Impact factor: 7.446

Review 5.  Targeting microtubules by natural agents for cancer therapy.

Authors:  Eiman Mukhtar; Vaqar Mustafa Adhami; Hasan Mukhtar
Journal:  Mol Cancer Ther       Date:  2014-01-16       Impact factor: 6.261

6.  Correct diffusion coefficients of proteins in fluorescence correlation spectroscopy. Application to tubulin oligomers induced by Mg2+ and Paclitaxel.

Authors:  Tatiana Krouglova; Jo Vercammen; Yves Engelborghs
Journal:  Biophys J       Date:  2004-10       Impact factor: 4.033

7.  Selective, covalent modification of beta-tubulin residue Cys-239 by T138067, an antitumor agent with in vivo efficacy against multidrug-resistant tumors.

Authors:  B Shan; J C Medina; E Santha; W P Frankmoelle; T C Chou; R M Learned; M R Narbut; D Stott; P Wu; J C Jaen; T Rosen; P B Timmermans; H Beckmann
Journal:  Proc Natl Acad Sci U S A       Date:  1999-05-11       Impact factor: 11.205

Review 8.  Recent progress on C-4-modified podophyllotoxin analogs as potent antitumor agents.

Authors:  Ying-Qian Liu; Jing Tian; Keduo Qian; Xiao-Bo Zhao; Susan L Morris-Natschke; Liu Yang; Xiang Nan; Xuan Tian; Kuo-Hsiung Lee
Journal:  Med Res Rev       Date:  2014-05-14       Impact factor: 12.944

9.  Antineoplastic agents. 552. Oxidation of combretastatin A-1: trapping the o-quinone intermediate considered the metabolic product of the corresponding phosphate prodrug.

Authors:  George R Pettit; Andrew J Thornhill; Bryan R Moser; Fiona Hogan
Journal:  J Nat Prod       Date:  2008-08-27       Impact factor: 4.050

Review 10.  The Curtius Rearrangement: Applications in Modern Drug Discovery and Medicinal Chemistry.

Authors:  Arun K Ghosh; Margherita Brindisi; Anindya Sarkar
Journal:  ChemMedChem       Date:  2018-10-11       Impact factor: 3.466

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.